Does diabetes medication reduce women's risk of coronary heart disease?
Washington, June 8, 2020, Tuesday
More research is being done on the Cora virus than on its transmission. Corona research results keep coming out from every corner of the world. A recent study found that regular use of a drug called metformin for diabetes reduced the risk of coronary heart disease in women, although surprisingly no side effects were reported in men. Researchers at the University of Minnesota say the drug has different effects on men and women. Women are also more effective in diabetes than men.
This drug reduces the amount of protein TNF alpha in the body, while recent research shows that increasing the amount of protein increases the symptoms of Covid-12. In addition to diabetes and obesity in the United States, a study of 200 women and men who were positive for Covid-12 was found to have a lower mortality rate for Covid-12 positive patients who completed a 30-day course of metformin, compared to female patients who did not take the drug. Mutudar was high.
However, even after the specialist doctors took into account all the aspects of the patient's physical and mental health and fitness factor, the mortality rate was found to be as low as 21 to 5 per cent. However, the drug did not make any difference in men. The drug metformin was tested on males and sick mice which was successful but is still being tested on humans so no conclusions should be drawn. So much so that the medical research that is coming out during the Corona period is very shocking. Corona's transition has become a challenge for medical science. This type of data is also useful for understanding the effects of medicine.
Comments
Post a Comment